Back to Trades
Apuli Maricel
Chief Accounting OfficerCIK 0002058197
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 11
- Buy transactions
- 0
- Sell transactions
- 5
- Companies
- 1
- Active
- 2025–2026
Apuli Maricel, Chief Accounting Officer, has filed 11 SEC reports (2025–2026), all concentrated in BridgeBio Pharma, Inc. (BBIO), totaling $2.3M in disclosed volume. Weighing $0 bought versus $535.1K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
11 loaded
| Aug 18 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | Tax withheld | $376.5K |
| Aug 3 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | Sell | $160.1K |
| May 19 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | Tax withheld | $311.7K |
| May 4 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | Sell | $143.2K |
| Mar 20 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | Grant | $0 |
| Feb 18 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | Sell | $37.9K |
| Dec 16 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | Tax withheld | $150.5K |
| Dec 10 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | Sell | $148.5K |
| Nov 18 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | Tax withheld | $317.4K |
| Aug 19 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Insider | Tax withheld | $245.4K |
| Aug 11 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel | Insider | Sell | $45.4K |
11 filings